| Hologic is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health. Co.'s segments: Diagnostics, which provides diagnostic products which are used to aid in the screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care for radiology, pathology and surgery; GYN Surgical, which include NovaSure Endometrial Ablation System to treat abnormal uterine bleeding and MyoSure Hysteroscopic Tissue Removal System, as well as Fluent Fluid Management system; and Skeletal Health, which includes the Horizon DXA, a dual energy x-ray system. |
When researching a stock like Hologic, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from HOLX Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for HOLX stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of these ways is called the Relative Strength Index, or RSI. This popular indicator, originally developed in the 1970's by J. Welles Wilder, looks at a 14-day moving average of a stock's gains on its up days, versus its losses on its down days. The resulting HOLX RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. A reading above 70 is viewed to be overbought, which could indicate that a rally in progress is starting to get crowded with buyers. If the rally has been a long one, that could be a sign that a pullback is overdue.